Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Rohit Aggarwal, MD,MS (he/him/his)

Professor
University of Pittsburgh
Pittsburgh, Pennsylvania, United States

Dr. Aggarwal is a professor of medicine at University of Pittsburgh and medical director of Arthritis and Autoimmunity Center at University of Pittsburgh Medical Center. He is the co-Director of UPMC Myositis Center. His research and clinical areas of interest are clinical and translational research in inflammatory muscle diseases (myositis) and associated interstitial lung disease. He is the past-chair of the medical advisory board of The Myositis Association (TMA) as well as past-chair of the scientific committee of IMACS, which are the largest patient and physician groups working in the field of myositis, respectively.

Presentation(s):

  • Decoding Anti-Synthetase Syndrome

    Sunday, October 26, 2025
    9:00 AM – 9:30 AM Central Time

    Disclosure(s): Alexion: Consultant (Ongoing); ANI Pharmaceuticals: Consultant (Ongoing); Argenx: Consultant (Ongoing); Artasome: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Cabaletta Bio: Consultant (Ongoing); Capella Bioscience: Consultant (Ongoing); Capstanx: Consultant (Ongoing); Corbus: Consultant (Ongoing); CSL Behring: Consultant (Ongoing); EMD Serono: Consultant (Ongoing), Grant/Research Support (Ongoing); Galapagos: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing); I-Cell: Consultant (Ongoing); Immunovant: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Kezar: Consultant (Ongoing); Kyverna: Consultant (Ongoing); Lilly: Consultant (Ongoing); Manta Medicines: Consultant (Ongoing); Nkarta: Consultant (Ongoing); Novartis: Consultant (Ongoing); Nuvig Therapeutics: Consultant (Ongoing); Octapharma: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); PRoivant: Consultant (Ongoing), Grant/Research Support (Ongoing); Teva: Consultant (Ongoing); Tourmaline Bio: Consultant (Ongoing); Verismo Therapeutics: Consultant (Ongoing)

  • Myositis 

    Sunday, October 26, 2025
    11:30 AM – 12:30 PM Central Time

    Disclosure information not submitted.

  • Myositis 

    Sunday, October 26, 2025
    4:00 PM – 5:00 PM Central Time

    Disclosure information not submitted.